SCA Pharmaceuticals 2023-08-02 Health serious FDA
Health · FDA · Recall #FDA-D-0945-2023
FentaNYL 500 mcg/250 mL - Bupivacaine HCl 0.1% in 0.9% Sodium Chloride 250mL Bag,… Recall
Issued August 2, 2023 · SCA Pharmaceuticals
In August 2023, SCA Pharmaceuticals recalled the FentaNYL 500 mcg/250 mL - Bupivacaine HCl 0.1% in 0.9% Sodium Chloride 250mL Bag,…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
cGMP deviations: due to shipment of rejected units.
What you should do
- 1 Stop using FentaNYL 500 mcg/250 mL - Bupivacaine HCl 0.1% in 0.9% Sodium Chloride 250mL Bag,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact SCA Pharmaceuticals to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- SCA Pharmaceuticals
- Category
- Health
- Recall date
- August 2, 2023
- Units affected
- Not reported
- Sold at
- KY and NJ
- Recall number
- FDA-D-0945-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- SCA Pharmaceuticals has 3 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.